Jose Ballesteros, MD
Interventional Cardiology · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 46 years
- Graduated 1980
Offices
1 location
Looking this up.
Hospitals listed: Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ballesteros’s office at (707) 527-8444 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C52195 · Current
Licensed to practise in California · since 2006 · expires 2027-07-31 · University of the East, Ramon Magsaysay Memorial Medical Center.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$167,900
Medicare paid this office $167,900 for 103 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 26 | $101,707 | $1,541 |
| Injection of chemical agent into single incompetent vein | 46 | $20,284 | $100 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 80 | $14,296 | $159 |
| Ultrasonic guidance for needle placement | 47 | $10,705 | $50 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 30 | $6,120 | $111 |
See all 8 services
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 26 | $101,707 | $1,541 |
| Injection of chemical agent into single incompetent vein | 46 | $20,284 | $100 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 80 | $14,296 | $159 |
| Ultrasonic guidance for needle placement | 47 | $10,705 | $50 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 30 | $6,120 | $111 |
| New patient visit (45+ min) | 34 | $4,404 | $130 |
| Return visit (30+ min) | 13 | $1,646 | $87 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $277 | $20 |
Procedures Medicare counted
| Varicose vein removal | 310 | More than 94% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of chemical agent into single incompetent vein | 297 | 332 | 184 | 237 | 314 | 202 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 48 | 71 | – | 37 | 50 | 66 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 71 | – | 73 | 67 | – | – |
| Injection of chemical agent into multiple incompetent veins of leg | 26 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
103 Original Medicare patients in 2024. Average age 74 · Women 73% · Also on Medicaid 38% · Health risk score 0.97. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 63% · Diabetes 22% · Atrial fibrillation 19% · Coronary heart disease 17% · Heart failure 15% · COPD 14% · Cancer 13% · Chronic kidney disease 12%.
The office billed $454,666, Medicare allowed $216,179 and paid $167,900; for 723 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 103 | 723 | 74 | 0.97 | $454,666 | $167,900 |
| 2023 | 104 | 966 | 75 | 1.08 | $478,182 | $165,109 |
| 2022 | 143 | 984 | 75 | 1.08 | $594,871 | $207,685 |
| 2021 | 229 | 1,228 | 76 | 1.42 | $584,080 | $218,177 |
| 2020 | 298 | 1,763 | 76 | 1.43 | $709,774 | $255,501 |
| 2019 | 527 | 2,216 | 76 | 1.64 | $785,542 | $312,940 |
| 2018 | 724 | 2,532 | 75 | 1.94 | $747,401 | $264,535 |
| 2017 | 824 | 2,961 | 75 | 1.65 | $942,097 | $344,517 |
| 2016 | 748 | 2,678 | 75 | 1.74 | $591,909 | $201,510 |
| 2015 | 711 | 2,935 | 75 | 1.58 | $683,197 | $244,983 |
| 2014 | 907 | 3,547 | 75 | 1.66 | $615,874 | $287,005 |
| 2013 | 719 | 2,772 | 74 | 1.58 | $417,638 | $229,136 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 24 | $79,284 | $1,586 |
| Injection of chemical agent into single incompetent vein | 51 | $31,396 | $100 |
| Ultrasonic guidance for needle placement | 52 | $16,491 | $50 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 77 | $12,985 | $149 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 34 | $6,013 | $107 |
| New patient visit (45+ min) | 37 | $5,200 | $141 |
| Return visit (30+ min) | 20 | $2,759 | $99 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $465 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $215 | $10 |
2022: 10 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 36 | $68,834 | $1,027 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 20 | $60,477 | $1,635 |
| Injection of chemical agent into single incompetent vein | 69 | $23,824 | $101 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 103 | $17,419 | $154 |
| Ultrasonic guidance for needle placement | 68 | $12,228 | $50 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 52 | $9,895 | $111 |
| New patient visit (45+ min) | 58 | $7,152 | $123 |
| Return visit (30+ min) | 26 | $3,205 | $94 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 33 | $717 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $201 | $11 |
2021: 15 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 32 | $86,640 | $1,187 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 106 | $19,301 | $161 |
| Injection of chemical agent into single incompetent vein | 58 | $17,639 | $96 |
| Ultrasonic guidance for needle placement | 58 | $9,151 | $49 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 42 | $7,903 | $115 |
| New patient visit (45+ min) | 52 | $7,015 | $135 |
| Long return visit (40+ min) | 43 | $6,878 | $119 |
| Return visit (30+ min) | 60 | $6,284 | $100 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 32 | $1,371 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $1,142 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 76 | $1,024 | $9 |
| Programming of dual lead pacemaker system | 11 | $991 | $58 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 33 | $969 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 21 | $963 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $609 | $24 |
2020: 17 services
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 33 | $117,072 | $1,649 |
| Injection of chemical agent into single incompetent vein | 70 | $29,082 | $88 |
| Ultrasonic guidance for needle placement | 70 | $15,590 | $46 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 84 | $14,932 | $157 |
| Long return visit (40+ min) | 93 | $12,553 | $102 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 51 | $8,791 | $99 |
| Return visit (30+ min) | 81 | $6,149 | $72 |
| New patient visit (45+ min) | 49 | $5,865 | $120 |
| Ultrasound of both sides of head and neck blood flow | 15 | $2,507 | $167 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 145 | $2,148 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 33 | $1,498 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $1,196 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $1,110 | $21 |
| Programming of dual lead pacemaker system | 14 | $949 | $47 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $734 | $27 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 32 | $612 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 19 | $135 | $7 |
2019: 19 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 31 | $89,234 | $1,257 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 25 | $87,829 | $1,830 |
| Injection of chemical agent into single incompetent vein | 74 | $26,343 | $89 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 114 | $19,459 | $157 |
| Long return visit (40+ min) | 130 | $17,733 | $105 |
| Ultrasonic guidance for needle placement | 77 | $15,308 | $48 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 60 | $11,560 | $107 |
| Ultrasound of both sides of head and neck blood flow | 59 | $9,442 | $160 |
| Return visit (30+ min) | 74 | $7,286 | $87 |
| New patient visit (45+ min) | 48 | $6,310 | $131 |
| Injection of chemical agent into multiple incompetent veins of leg | 17 | $3,872 | $149 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 50 | $3,117 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 171 | $2,788 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 196 | $1,680 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 34 | $1,599 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $1,343 | $20 |
| Programming of dual lead pacemaker system | 16 | $1,221 | $49 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 35 | $711 | $19 |
| Evaluation of implantable heart and blood vessel monitoring system | 13 | $634 | $30 |
2018: 26 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 42 | $91,135 | $1,232 |
| Long return visit (40+ min) | 199 | $25,612 | $94 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 123 | $21,222 | $147 |
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 12 | $20,714 | $986 |
| Injection of chemical agent into single incompetent vein | 74 | $15,622 | $80 |
| Ultrasonic guidance for needle placement | 88 | $13,028 | $47 |
| Injection of chemical agent into multiple incompetent veins of leg | 52 | $12,124 | $141 |
| Ultrasound of both sides of head and neck blood flow | 73 | $12,026 | $163 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 55 | $8,893 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $5,210 | $59 |
| New patient visit (45+ min) | 40 | $4,521 | $113 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 322 | $3,060 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 200 | $2,896 | $10 |
| Aspiration of abscess, blood, or cyst | 12 | $1,995 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 37 | $1,573 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,125 | $39 |
| Return visit (30+ min) | 15 | $1,118 | $75 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 26 | $1,106 | $20 |
| Programming of dual lead pacemaker system | 16 | $926 | $44 |
| Evaluation of implantable heart and blood vessel monitoring system | 20 | $629 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $594 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $396 | $28 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $383 | $17 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $272 | $21 |
| External ekg recording for more than 48 hours up to 21 days | 13 | $252 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $134 | $10 |
2017: 22 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 40 | $85,772 | $1,300 |
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 44 | $75,067 | $1,014 |
| Long return visit (40+ min) | 230 | $37,712 | $107 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 135 | $21,854 | $155 |
| Injection of chemical agent into multiple incompetent veins of leg | 65 | $16,402 | $134 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 93 | $14,248 | $99 |
| Injection of chemical agent into single incompetent vein | 63 | $13,422 | $109 |
| Ultrasound of both sides of head and neck blood flow | 78 | $13,176 | $169 |
| Ultrasonic guidance for needle placement | 93 | $11,945 | $50 |
| New patient visit (45+ min) | 61 | $7,602 | $125 |
| Return visit (30+ min) | 82 | $5,203 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $4,852 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 248 | $4,695 | $11 |
| Complete ultrasound study of arm and leg arteries | 42 | $3,509 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 361 | $3,056 | $7 |
| Aspiration of abscess, blood, or cyst | 14 | $2,226 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 40 | $2,026 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 30 | $1,947 | $25 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,162 | $51 |
| Evaluation of implantable heart and blood vessel monitoring system | 17 | $578 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $455 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $163 | $10 |
2016: 27 services
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 28 | $44,049 | $958 |
| Return visit (30+ min) | 294 | $37,227 | $76 |
| Ultrasound of both sides of head and neck blood flow | 106 | $17,183 | $156 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 83 | $13,218 | $147 |
| Injection of chemical agent into single incompetent vein | 34 | $9,579 | $108 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 86 | $7,415 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 300 | $5,932 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 114 | $5,905 | $50 |
| New patient visit (45+ min) | 47 | $5,891 | $125 |
| Ultrasonic guidance for needle placement | 38 | $4,974 | $49 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 29 | $3,758 | $87 |
| Ultrasound of leg arteries or artery grafts | 23 | $3,590 | $156 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,324 | $208 |
| Complete ultrasound study of arm and leg arteries | 32 | $2,786 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,412 | $161 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 269 | $2,373 | $7 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 15 | $2,081 | $139 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 34 | $1,872 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 41 | $1,839 | $20 |
| Injection of chemical agent into multiple incompetent veins of leg | 13 | $1,724 | $133 |
| Programming of dual lead pacemaker system | 25 | $1,451 | $41 |
| Long return visit (40+ min) | 11 | $985 | $82 |
| Short return visit (20+ min) | 11 | $558 | $51 |
| Evaluation of implantable heart and blood vessel monitoring system | 16 | $482 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 20 | $405 | $20 |
| External ekg recording for more than 48 hours up to 21 days | 15 | $274 | $18 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $261 | $15 |
2015: 30 services
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 28 | $51,052 | $1,001 |
| Return visit (30+ min) | 314 | $37,741 | $82 |
| Ultrasound of both sides of head and neck blood flow | 127 | $21,525 | $162 |
| Injection of chemical agent into single incompetent vein | 37 | $14,852 | $117 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 66 | $11,589 | $155 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 163 | $8,749 | $51 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,470 | $439 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 352 | $7,417 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | $7,103 | $209 |
| Ultrasonic guidance for needle placement | 37 | $6,544 | $50 |
| Ultrasound of leg arteries or artery grafts | 32 | $6,079 | $184 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 64 | $5,832 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,376 | $163 |
| Long return visit (40+ min) | 44 | $5,140 | $107 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 35 | $4,823 | $100 |
| New patient visit (45+ min) | 37 | $4,620 | $125 |
| Short return visit (20+ min) | 69 | $2,802 | $40 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 21 | $2,754 | $131 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 40 | $2,015 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 29 | $1,979 | $25 |
| Ultrasound study of arm and leg arteries | 31 | $1,847 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,628 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 139 | $1,436 | $7 |
| Complete ultrasound study of arm and leg arteries | 15 | $1,379 | $92 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,315 | $49 |
| Programming of dual lead pacemaker system | 15 | $1,265 | $42 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 26 | $561 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $557 | $20 |
| Evaluation of implantable heart and blood vessel monitoring system | 11 | $513 | $23 |
| External ekg recording for more than 48 hours up to 21 days | 25 | $490 | $20 |
2014: 33 services
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 38 | $70,507 | $1,119 |
| Return visit (30+ min) | 281 | $32,286 | $80 |
| Long return visit (40+ min) | 129 | $18,144 | $110 |
| Ultrasound of both sides of head and neck blood flow | 92 | $14,778 | $154 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 91 | $14,173 | $143 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 237 | $13,298 | $52 |
| Ultrasonic guidance for needle placement | 39 | $8,514 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 351 | $8,471 | $13 |
| Injection of chemical agent into single incompetent vein | 32 | $7,838 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,192 | $163 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $6,766 | $211 |
| Short return visit (20+ min) | 121 | $6,296 | $48 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 73 | $6,107 | $80 |
| Injection of chemical agent into multiple incompetent veins of leg | 23 | $5,988 | $143 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 48 | $5,523 | $92 |
| Ultrasound of leg arteries or artery grafts | 28 | $5,465 | $182 |
| New patient visit (60+ min) | 31 | $4,972 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,129 | $58 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 23 | $4,125 | $159 |
| Complete ultrasound study of arm and leg arteries | 44 | $4,061 | $90 |
| New patient visit (45+ min) | 32 | $4,048 | $126 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 345 | $3,287 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 39 | $1,700 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $1,612 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 26 | $1,393 | $24 |
| Ultrasound study of arm and leg arteries | 22 | $1,245 | $57 |
| Programming of dual lead pacemaker system | 17 | $942 | $35 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 14 | $733 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $692 | $58 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 15 | $638 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system | 13 | $465 | $21 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 21 | $399 | $19 |
| External ekg recording for more than 48 hours up to 21 days | 21 | $272 | $13 |
2013: 31 services
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 23 | $44,541 | $1,172 |
| Return visit (30+ min) | 216 | $27,105 | $75 |
| Ultrasonic guidance for needle placement | 25 | $20,036 | $177 |
| Ultrasound of both sides of head and neck blood flow | 88 | $13,874 | $151 |
| Long return visit (40+ min) | 105 | $13,517 | $97 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 65 | $10,154 | $156 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 282 | $8,288 | $14 |
| Short return visit (20+ min) | 119 | $7,752 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 137 | $6,991 | $50 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 13 | $6,474 | $498 |
| Injection of chemical agent into single incompetent vein | 20 | $6,084 | $127 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,759 | $207 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 55 | $4,689 | $84 |
| New patient visit (60+ min) | 28 | $4,384 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,244 | $157 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 30 | $3,869 | $97 |
| Injection of chemical agent into multiple incompetent veins of leg | 14 | $3,376 | $125 |
| Ultrasound of leg arteries or artery grafts | 19 | $3,082 | $162 |
| Ultrasound study of arm and leg arteries | 45 | $2,937 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,323 | $57 |
| Programming of dual lead pacemaker system | 22 | $1,971 | $41 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 249 | $1,959 | $7 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $1,717 | $156 |
| New patient visit (45+ min) | 12 | $1,571 | $131 |
| Complete ultrasound study of arm and leg arteries | 12 | $1,159 | $97 |
| New patient visit (30+ min) | 16 | $1,099 | $69 |
| Evaluation of implantable heart and blood vessel monitoring system | 19 | $708 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 27 | $688 | $18 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $618 | $39 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 17 | $574 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $246 | $15 |
Medicaid work
$822,794 in 2024
Medicaid paid $822,794 for 1,983 billed services this clinician did in 2024, up to 51 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated | 261 | $673,476 |
| Injection of chemical agent into single incompetent vein | 592 | $48,536 |
| EXTREMITY STUDY | 238 | $46,776 |
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 663 | $30,929 |
| EXTREMITY STUDY | 200 | $20,008 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 29 | $3,069 |
| 2024 | 1,983 | 6 | 51 | $822,794 |
| 2023 | 1,468 | 4 | 30 | $160,678 |
| 2022 | 1,413 | 6 | 33 | $314,228 |
| 2021 | 1,331 | 6 | 29 | $286,821 |
| 2020 | 857 | 6 | 27 | $97,557 |
| 2019 | 871 | 6 | 34 | $74,812 |
| 2018 | 427 | 7 | 32 | $106,098 |
See the largest Medicaid services in earlier years
2023
| Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated | 19 | $49,129 |
| Injection of chemical agent into single incompetent vein | 584 | $43,082 |
| EXTREMITY STUDY | 225 | $41,937 |
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 640 | $26,530 |
2022
| Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated | 106 | $216,570 |
| EXTREMITY STUDY | 206 | $36,205 |
| Injection of chemical agent into single incompetent vein | 487 | $34,948 |
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 537 | $21,260 |
| EXTREMITY STUDY | 64 | $5,073 |
| OFF/OP EST MAY X REQ PHY/QHP | 13 | $172 |
2021
| Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated | 94 | $190,413 |
| EXTREMITY STUDY | 206 | $34,535 |
| Injection of chemical agent into single incompetent vein | 479 | $33,428 |
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 489 | $24,033 |
| EXTREMITY STUDY | 51 | $4,287 |
| OFF/OP EST MAY X REQ PHY/QHP | 12 | $125 |
2020
| Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated | 16 | $36,826 |
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 375 | $21,227 |
| Injection of chemical agent into single incompetent vein | 349 | $21,115 |
| EXTREMITY STUDY | 80 | $14,883 |
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 19 | $1,952 |
| EXTREMITY STUDY | 18 | $1,555 |
2019
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 399 | $32,298 |
| Injection of chemical agent into single incompetent vein | 301 | $23,690 |
| EXTREMITY STUDY | 48 | $10,431 |
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 64 | $6,830 |
| EXTREMITY STUDY | 14 | $1,004 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 45 | $559 |
2018
| Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated | 31 | $73,361 |
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 190 | $15,688 |
| Injection of chemical agent into single incompetent vein | 86 | $7,447 |
| EXTREMITY STUDY | 29 | $6,124 |
| EXTREMITY STUDY | 13 | $1,429 |
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 14 | $1,301 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 64 | $748 |
Drugs they prescribed that Part D paid
$20,628
Pharmacies billed $20,628 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 80) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
68 generic and 12 brand-name prescriptions · $20,628 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 11 | $122 | $11 |
Year by year
| 2024 | 80 | 18 | 0% (0) | 15% | $20,628 |
| 2023 | 115 | 14 | 0% (0) | None | $22,556 |
| 2022 | 313 | 51 | 0% (0) | 21% | $66,730 |
| 2021 | 722 | 99 | 0% (0) | 21% | $128,166 |
| 2020 | 1,401 | 132 | 0% (0) | 18% | $151,209 |
| 2019 | 1,906 | 171 | 0% (0) | 13% | $138,670 |
| 2018 | 2,374 | 203 | 0% (0) | 12% | $150,227 |
| 2017 | 2,912 | 221 | 0% (0) | 12% | $118,818 |
| 2016 | 3,352 | 242 | 0% (0) | None | $141,305 |
| 2015 | 3,378 | 264 | 0% (0) | None | $129,187 |
| 2014 | 3,273 | 248 | None | None | $125,669 |
| 2013 | 3,291 | 230 | None | None | $118,630 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Atorvastatin | 22 | $406 | $18 |
| Amlodipine Besylate | 18 | $104 | $6 |
2022: 8 drugs
| Eliquis | 19 | $21,425 | $1,128 |
| Xarelto | 19 | $16,034 | $844 |
| Atorvastatin | 53 | $645 | $12 |
| Metoprolol | 19 | $575 | $30 |
| Amlodipine Besylate | 30 | $393 | $13 |
| Carvedilol | 27 | $340 | $13 |
| Benazepril | 15 | $319 | $21 |
| Rosuvastatin | 11 | $278 | $25 |
2021: 17 drugs
| Eliquis | 54 | $40,029 | $741 |
| Xarelto | 40 | $36,608 | $915 |
| Entresto | 20 | $18,222 | $911 |
| Praluent | 19 | $12,598 | $663 |
| Atorvastatin | 133 | $2,319 | $17 |
| Flecainide Acetate | 19 | $1,353 | $71 |
| Carvedilol | 48 | $1,193 | $25 |
| Rosuvastatin | 35 | $1,171 | $33 |
| Metoprolol | 35 | $1,072 | $31 |
| Olmesartan Medoxomil | 15 | $937 | $62 |
| Benazepril | 38 | $796 | $21 |
| Irbesartan-Hydrochlorothiazide | 19 | $556 | $29 |
| Amlodipine Besylate | 43 | $528 | $12 |
| Potassium Chloride | 13 | $408 | $31 |
| Simvastatin | 29 | $350 | $12 |
| Lisinopril | 28 | $290 | $10 |
| Olmesartan-Hydrochlorothiazide | 11 | $173 | $16 |
2020: 28 drugs
| Eliquis | 110 | $60,436 | $549 |
| Xarelto | 39 | $29,429 | $755 |
| Entresto | 15 | $15,600 | $1,040 |
| Atorvastatin | 261 | $5,949 | $23 |
| Carvedilol | 116 | $3,810 | $33 |
| Carvedilol Er | 13 | $2,715 | $209 |
| Metoprolol | 64 | $2,389 | $37 |
| Bystolic | 12 | $1,904 | $159 |
| Irbesartan-Hydrochlorothiazide | 28 | $1,297 | $46 |
| Amlodipine Besylate | 103 | $1,160 | $11 |
| Rosuvastatin | 32 | $1,066 | $33 |
| Flecainide Acetate | 28 | $984 | $35 |
| Benazepril | 54 | $966 | $18 |
| Amiodarone | 17 | $921 | $54 |
| Lisinopril | 82 | $822 | $10 |
| Potassium Chloride | 32 | $726 | $23 |
| Simvastatin | 64 | $639 | $10 |
| Valsartan | 13 | $612 | $47 |
| Sotalol | 11 | $547 | $50 |
| Isosorbide Mononitrate Er | 20 | $469 | $23 |
| Clopidogrel | 17 | $455 | $27 |
| Olmesartan-Hydrochlorothiazide | 20 | $386 | $19 |
| Metoprolol | 24 | $358 | $15 |
| Clonidine | 11 | $294 | $27 |
| Losartan | 17 | $259 | $15 |
| Ezetimibe | 11 | $255 | $23 |
| Furosemide | 36 | $194 | $5 |
| Hydrochlorothiazide | 13 | $99 | $8 |
2019: 36 drugs
| Eliquis | 67 | $34,946 | $522 |
| Xarelto | 40 | $29,318 | $733 |
| Praluent | 21 | $19,439 | $926 |
| Atorvastatin | 291 | $7,349 | $25 |
| Metoprolol | 60 | $2,526 | $42 |
| Carvedilol Er | 13 | $2,167 | $167 |
| Rosuvastatin | 42 | $1,709 | $41 |
| Amlodipine Besylate | 151 | $1,549 | $10 |
| Carvedilol | 152 | $1,511 | $10 |
| Dilt-Xr | 41 | $1,291 | $31 |
| Lisinopril | 115 | $1,019 | $9 |
| Benazepril | 82 | $1,002 | $12 |
| Valsartan | 12 | $991 | $83 |
| Irbesartan | 23 | $949 | $41 |
| Amiodarone | 40 | $923 | $23 |
| Simvastatin | 85 | $843 | $10 |
| Potassium Chloride | 33 | $842 | $26 |
| Flecainide Acetate | 25 | $647 | $26 |
| Irbesartan-Hydrochlorothiazide | 22 | $595 | $27 |
| Olmesartan Medoxomil | 28 | $580 | $21 |
| Clopidogrel | 36 | $576 | $16 |
| Olmesartan-Hydrochlorothiazide | 21 | $542 | $26 |
| Sotalol | 13 | $538 | $41 |
| Metoprolol | 58 | $477 | $8 |
| Isosorbide Mononitrate Er | 20 | $422 | $21 |
| Losartan | 40 | $409 | $10 |
| Diltiazem 24hr Er (Cd) | 12 | $397 | $33 |
| Spironolactone | 48 | $341 | $7 |
| Furosemide | 82 | $328 | $4 |
| Cartia Xt | 20 | $310 | $15 |
| Atenolol | 11 | $292 | $27 |
| Digoxin | 12 | $289 | $24 |
| Warfarin | 23 | $284 | $12 |
| Diltiazem 24hr Er | 15 | $271 | $18 |
| Clonidine | 18 | $231 | $13 |
| Hydrochlorothiazide | 17 | $96 | $6 |
2018: 37 drugs
| Xarelto | 52 | $31,006 | $596 |
| Eliquis | 45 | $29,720 | $660 |
| Praluent | 25 | $29,129 | $1,165 |
| Atorvastatin | 367 | $9,527 | $26 |
| Metoprolol | 76 | $3,005 | $40 |
| Omega-3 Acid Ethyl Esters | 20 | $2,108 | $105 |
| Rosuvastatin | 53 | $2,040 | $38 |
| Amlodipine Besylate | 209 | $1,881 | $9 |
| Olmesartan Medoxomil | 32 | $1,718 | $54 |
| Carvedilol | 191 | $1,632 | $9 |
| Potassium Chloride | 62 | $1,456 | $23 |
| Valsartan | 36 | $1,337 | $37 |
| Lisinopril | 140 | $1,115 | $8 |
| Benazepril | 89 | $974 | $11 |
| Isosorbide Mononitrate Er | 25 | $867 | $35 |
| Irbesartan-Hydrochlorothiazide | 37 | $840 | $23 |
| Dilt-Xr | 24 | $762 | $32 |
| Warfarin | 50 | $753 | $15 |
| Clopidogrel | 61 | $748 | $12 |
| Valsartan-Hydrochlorothiazide | 30 | $741 | $25 |
| Irbesartan | 24 | $685 | $29 |
| Simvastatin | 90 | $663 | $7 |
| Diltiazem 24hr Er (Cd) | 18 | $658 | $37 |
| Amiodarone | 53 | $653 | $12 |
| Sotalol | 30 | $545 | $18 |
| Flecainide Acetate | 23 | $514 | $22 |
| Spironolactone | 55 | $495 | $9 |
| Cartia Xt | 25 | $493 | $20 |
| Digoxin | 12 | $427 | $36 |
| Metoprolol | 62 | $388 | $6 |
| Furosemide | 105 | $382 | $4 |
| Diltiazem 24hr Er (Xr) | 11 | $376 | $34 |
| Losartan | 49 | $317 | $6 |
| Clonidine | 18 | $269 | $15 |
| Atenolol | 14 | $238 | $17 |
| Jantoven | 11 | $91 | $8 |
| Hydrochlorothiazide | 15 | $70 | $5 |
2017: 39 drugs
| Praluent | 16 | $18,684 | $1,168 |
| Xarelto | 18 | $11,175 | $621 |
| Atorvastatin | 529 | $10,571 | $20 |
| Eliquis | 21 | $9,002 | $429 |
| Olmesartan Medoxomil | 32 | $4,466 | $140 |
| Coreg Cr | 13 | $3,340 | $257 |
| Rosuvastatin | 77 | $3,326 | $43 |
| Metoprolol | 79 | $2,903 | $37 |
| Carvedilol | 246 | $2,532 | $10 |
| Propafenone | 17 | $2,492 | $147 |
| Amlodipine Besylate | 337 | $2,480 | $7 |
| Potassium Chloride | 65 | $2,022 | $31 |
| Valsartan-Hydrochlorothiazide | 65 | $1,487 | $23 |
| Lisinopril | 161 | $1,362 | $8 |
| Warfarin | 80 | $1,358 | $17 |
| Valsartan | 63 | $1,353 | $21 |
| Benazepril | 113 | $1,261 | $11 |
| Diltiazem 24hr Er | 53 | $1,109 | $21 |
| Simvastatin | 103 | $778 | $8 |
| Digoxin | 17 | $708 | $42 |
| Amiodarone | 55 | $688 | $13 |
| Irbesartan | 19 | $619 | $33 |
| Furosemide | 131 | $583 | $4 |
| Irbesartan-Hydrochlorothiazide | 23 | $552 | $24 |
| Clopidogrel | 49 | $536 | $11 |
| Cartia Xt | 24 | $490 | $20 |
| Metoprolol | 70 | $485 | $7 |
| Spironolactone | 48 | $450 | $9 |
| Isosorbide Mononitrate Er | 25 | $409 | $16 |
| Diltiazem Er | 12 | $406 | $34 |
| Clonidine | 28 | $376 | $13 |
| Losartan | 45 | $325 | $7 |
| Sotalol | 22 | $265 | $12 |
| Flecainide Acetate | 13 | $246 | $19 |
| Atenolol | 21 | $204 | $10 |
| Ramipril | 12 | $126 | $11 |
| Hydrochlorothiazide | 32 | $107 | $3 |
| Jantoven | 11 | $88 | $8 |
| Lisinopril-Hydrochlorothiazide | 14 | $87 | $6 |
2016: 42 drugs
| Crestor | 68 | $20,716 | $305 |
| Praluent | 14 | $15,668 | $1,119 |
| Atorvastatin | 562 | $10,464 | $19 |
| Xarelto | 19 | $9,914 | $522 |
| Benicar | 43 | $8,853 | $206 |
| Effient | 18 | $6,867 | $381 |
| Eliquis | 17 | $5,374 | $316 |
| Rosuvastatin | 21 | $4,237 | $202 |
| Tekturna Hct | 16 | $3,845 | $240 |
| Amlodipine Besylate | 363 | $3,058 | $8 |
| Coreg Cr | 14 | $2,967 | $212 |
| Potassium Chloride | 87 | $2,596 | $30 |
| Metoprolol | 85 | $2,592 | $30 |
| Carvedilol | 268 | $2,395 | $9 |
| Bystolic | 15 | $2,202 | $147 |
| Valsartan | 72 | $2,065 | $29 |
| Diltiazem 24hr Er | 79 | $1,967 | $25 |
| Lisinopril | 178 | $1,522 | $9 |
| Benazepril | 123 | $1,205 | $10 |
| Warfarin | 87 | $1,201 | $14 |
| Simvastatin | 144 | $1,177 | $8 |
| Propafenone | 24 | $1,057 | $44 |
| Clopidogrel | 91 | $972 | $11 |
| Irbesartan-Hydrochlorothiazide | 38 | $894 | $24 |
| Valsartan-Hydrochlorothiazide | 39 | $842 | $22 |
| Irbesartan | 35 | $826 | $24 |
| Furosemide | 145 | $808 | $6 |
| Amiodarone | 70 | $802 | $11 |
| Metoprolol | 113 | $798 | $7 |
| Diltiazem Er | 27 | $796 | $29 |
| Isosorbide Mononitrate Er | 53 | $578 | $11 |
| Diltiazem 24hr Cd | 22 | $491 | $22 |
| Losartan | 44 | $446 | $10 |
| Spironolactone | 49 | $435 | $9 |
| Clonidine | 41 | $405 | $10 |
| Digoxin | 13 | $361 | $28 |
| Atenolol | 26 | $345 | $13 |
| Pravastatin | 14 | $276 | $20 |
| Sotalol | 17 | $262 | $15 |
| Ramipril | 12 | $174 | $15 |
| Hydrochlorothiazide | 25 | $152 | $6 |
| Jantoven | 13 | $110 | $8 |
2015: 44 drugs
| Crestor | 65 | $18,641 | $287 |
| Xarelto | 36 | $11,612 | $323 |
| Atorvastatin | 470 | $8,569 | $18 |
| Benicar | 47 | $8,526 | $181 |
| Effient | 25 | $7,908 | $316 |
| Multaq | 12 | $5,613 | $468 |
| Diovan | 13 | $5,098 | $392 |
| Benicar Hct | 16 | $4,751 | $297 |
| Metoprolol | 88 | $3,241 | $37 |
| Tekturna Hct | 16 | $3,211 | $201 |
| Bystolic | 21 | $3,001 | $143 |
| Valsartan | 37 | $2,721 | $74 |
| Potassium Chloride | 96 | $2,566 | $27 |
| Coreg Cr | 15 | $2,528 | $169 |
| Carvedilol | 295 | $2,436 | $8 |
| Amlodipine Besylate | 358 | $1,972 | $6 |
| Simvastatin | 218 | $1,579 | $7 |
| Warfarin | 97 | $1,524 | $16 |
| Lisinopril | 162 | $1,294 | $8 |
| Clopidogrel | 114 | $1,110 | $10 |
| Benazepril | 126 | $1,024 | $8 |
| Valsartan-Hydrochlorothiazide | 36 | $1,010 | $28 |
| Irbesartan | 60 | $873 | $15 |
| Metoprolol | 128 | $784 | $6 |
| Diltiazem Er | 40 | $772 | $19 |
| Isosorbide Mononitrate Er | 57 | $772 | $14 |
| Proair Hfa | 12 | $739 | $62 |
| Furosemide | 170 | $730 | $4 |
| Eplerenone | 11 | $722 | $66 |
| Diltiazem 24hr Cd | 22 | $636 | $29 |
| Propafenone | 30 | $614 | $20 |
| Nitrostat | 14 | $608 | $43 |
| Digoxin | 20 | $602 | $30 |
| Amiodarone | 57 | $600 | $11 |
| Spironolactone | 50 | $466 | $9 |
| Losartan | 62 | $402 | $6 |
| Irbesartan-Hydrochlorothiazide | 32 | $349 | $11 |
| Clonidine | 23 | $330 | $14 |
| Dilt-Xr | 11 | $316 | $29 |
| Pravastatin | 14 | $284 | $20 |
| Sotalol | 15 | $246 | $16 |
| Atenolol | 26 | $208 | $8 |
| Ramipril | 11 | $152 | $14 |
| Losartan-Hydrochlorothiazide | 14 | $100 | $7 |
2014: 42 drugs
| Xarelto | 36 | $12,217 | $339 |
| Crestor | 45 | $11,226 | $249 |
| Diovan | 41 | $8,101 | $198 |
| Atorvastatin | 375 | $6,893 | $18 |
| Effient | 25 | $6,770 | $271 |
| Benicar | 39 | $5,670 | $145 |
| Ranexa | 17 | $5,558 | $327 |
| Benicar Hct | 18 | $4,802 | $267 |
| Valsartan | 20 | $4,169 | $208 |
| Metoprolol | 95 | $3,857 | $41 |
| Tekturna Hct | 16 | $2,911 | $182 |
| Carvedilol | 257 | $2,425 | $9 |
| Amlodipine Besylate | 286 | $2,129 | $7 |
| Coreg Cr | 20 | $1,935 | $97 |
| Simvastatin | 245 | $1,856 | $8 |
| Potassium Chloride | 81 | $1,793 | $22 |
| Exforge Hct | 12 | $1,777 | $148 |
| Irbesartan | 84 | $1,703 | $20 |
| Clopidogrel | 88 | $1,423 | $16 |
| Bystolic | 15 | $1,356 | $90 |
| Nitrostat | 22 | $1,355 | $62 |
| Lisinopril | 201 | $1,196 | $6 |
| Benazepril | 107 | $1,176 | $11 |
| Diltiazem 24hr Er | 38 | $1,160 | $31 |
| Warfarin | 83 | $1,110 | $13 |
| Propafenone | 24 | $1,051 | $44 |
| Irbesartan-Hydrochlorothiazide | 35 | $948 | $27 |
| Metoprolol | 137 | $893 | $7 |
| Diltiazem Er | 21 | $873 | $42 |
| Losartan | 84 | $811 | $10 |
| Digoxin | 25 | $772 | $31 |
| Valsartan-Hydrochlorothiazide | 26 | $755 | $29 |
| Furosemide | 221 | $751 | $3 |
| Isosorbide Mononitrate Er | 29 | $613 | $21 |
| Spironolactone | 85 | $546 | $6 |
| Digox | 11 | $531 | $48 |
| Pravastatin | 20 | $494 | $25 |
| Amiodarone | 43 | $484 | $11 |
| Clonidine | 25 | $331 | $13 |
| Atenolol | 29 | $230 | $8 |
| Bumetanide | 12 | $177 | $15 |
| Prazosin | 11 | $161 | $15 |
2013: 39 drugs
| Diovan | 83 | $11,124 | $134 |
| Crestor | 46 | $10,256 | $223 |
| Atorvastatin | 359 | $9,976 | $28 |
| Benicar | 46 | $8,511 | $185 |
| Tekturna Hct | 40 | $5,219 | $130 |
| Metoprolol | 127 | $5,142 | $40 |
| Benicar Hct | 23 | $5,031 | $219 |
| Effient | 17 | $3,889 | $229 |
| Bystolic | 38 | $3,462 | $91 |
| Clopidogrel | 93 | $2,814 | $30 |
| Amlodipine Besylate | 353 | $2,775 | $8 |
| Simvastatin | 266 | $2,507 | $9 |
| Carvedilol | 226 | $2,433 | $11 |
| Irbesartan | 66 | $1,842 | $28 |
| Lisinopril | 238 | $1,760 | $7 |
| Tekturna | 13 | $1,592 | $122 |
| Valsartan-Hydrochlorothiazide | 26 | $1,592 | $61 |
| Metoprolol | 154 | $1,216 | $8 |
| Potassium Chloride | 51 | $1,192 | $23 |
| Losartan | 74 | $1,187 | $16 |
| Diltiazem 24hr Er | 34 | $1,091 | $32 |
| Benazepril | 90 | $1,021 | $11 |
| Propafenone | 11 | $909 | $83 |
| Amiodarone | 58 | $896 | $15 |
| Irbesartan-Hydrochlorothiazide | 29 | $889 | $31 |
| Warfarin | 57 | $888 | $16 |
| Diltiazem Er | 18 | $817 | $45 |
| Spironolactone | 98 | $785 | $8 |
| Nitrostat | 15 | $761 | $51 |
| Furosemide | 161 | $554 | $3 |
| Klor-Con M20 | 20 | $374 | $19 |
| Clonidine | 32 | $368 | $12 |
| Isosorbide Mononitrate Er | 16 | $354 | $22 |
| Pravastatin | 20 | $330 | $17 |
| Losartan-Hydrochlorothiazide | 11 | $215 | $20 |
| Prazosin | 12 | $170 | $14 |
| Digoxin | 28 | $136 | $5 |
| Atenolol | 17 | $101 | $6 |
| Digox | 13 | $93 | $7 |
Money from drug and device companies
$139 in 2025
| 2025 | 1 | 5 | None | $139 |
| 2024 | 2 | 3 | None | $58 |
| 2023 | 2 | 2 | None | $45 |
| 2022 | 6 | 7 | None | $158 |
| 2021 | 3 | 10 | None | $266 |
| 2020 | 5 | 13 | None | $298 |
| 2019 | 5 | 7 | None | $229 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Venaseal | $139 | 5 payments
|
See all 5 published payments
| Medtronic | Meals · 2025-10-17 | Venaseal | $22 |
| Medtronic | Meals · 2025-10-17 | Venaseal | $36 |
| Medtronic | Meals · 2025-07-01 | Venaseal | $30 |
| Medtronic | Meals · 2025-04-01 | Closurefast | $26 |
| Medtronic | Meals · 2025-02-20 | Venaseal | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $58
| Amgen | Repatha | $30 | 1 payment
|
| Medtronic | Venaseal | $28 | 2 payments
|
2023: $45
| Actelion Pharmaceuticals US | Opsumit | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $22 | 1 payment
|
2022: $158
| Bardy Diagnostics | Carnation Ambulatory Monitor | $48 | 2 payments
|
| Medtronic | Venaseal | $25 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $25 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $24 | 1 payment
|
| Boston Scientific | Varithena Administration Pack | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $14 | 1 payment
|
2021: $266
| Bardy Diagnostics | Carnation Ambulatory Monitor | $182 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $45 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $39 | 2 payments
|
2020: $298
| Medtronic Vascular | Venaseal | $114 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $95 | 5 payments
|
| Amarin Pharma | Vascepa | $44 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $31 | 2 payments
|
| AngioDynamics | None | $13 | 1 payment
|
2019: $229
| Medtronic Vascular | Venaseal | $143 | 3 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $26 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $23 | 1 payment
|
| Sanofi-Aventis U.S. | Praluent | $23 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $14 | 1 payment
|
Professional record
- NPI
- 1770527269
- Licence
- CA C52195California C52195: Current · expires 2027-07-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA GR0065700
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 990 Sonoma Ave Ste 2, Santa Rosa, CA, 95404
- NPI first listed
- 2006-06-15
- NPI last updated
- 2026-03-26
- NPI record certified
- 2026-03-26
This is when the NPI record was last certified, not a medical board exam.